Partner Content Partner Content Only 4 Weeks Until Orphan Drugs & Rare Diseases 2018 Pharma Giants Unite to Improve Rare Disease Treatment
Partner Content Partner Content Patient Organisations role in Orphan Drugs clinical developm... Orphan Drugs and Rare Diseases Conference - London
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
